News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,778 Results
Type
Article (16526)
Company Profile (39)
Press Release (267213)
Section
Business (81274)
Career Advice (681)
Deals (15026)
Drug Delivery (31)
Drug Development (43037)
Employer Resources (73)
FDA (7500)
Job Trends (6448)
News (148470)
Policy (13965)
Tag
Academia (1420)
Africa (348)
Alliances (21353)
Alzheimer's disease (522)
Approvals (7474)
Arizona (38)
Artificial intelligence (27)
Asia (17119)
Australia (2843)
Bankruptcy (121)
Best Places to Work (5282)
Biotechnology (27)
Breast cancer (28)
C2C Services and Suppliers (28679)
California (643)
Canada (398)
Cancer (233)
Career advice (573)
Cell therapy (47)
China (63)
Clinical research (34488)
Collaboration (54)
Colorado (25)
Connecticut (34)
COVID-19 (2099)
Data (180)
Diabetes (35)
Diagnostics (2827)
Diversity, equity & inclusion (28)
Drug pricing (25)
Earnings (29475)
Employer resources (66)
Europe (43099)
Events (39005)
Executive appointments (61)
FDA (7613)
Florida (93)
Funding (65)
Gene therapy (45)
Georgia (30)
GLP-1 (237)
Government (1995)
Healthcare (8425)
Hotbed/Location (195075)
Illinois (96)
Indiana (60)
Infectious disease (2111)
Inflammatory bowel disease (42)
Interviews (111)
IPO (6082)
Job creations (1232)
Job search strategy (516)
Kansas (36)
Layoffs (103)
Legal (2866)
Liver cancer (24)
Lung cancer (56)
Manufacturing (29)
Maryland (155)
Massachusetts (436)
Medical device (5162)
Medtech (5164)
Mergers & acquisitions (8915)
Metabolic disorders (90)
Michigan (26)
Minnesota (72)
Neuroscience (592)
New Hampshire (50)
New Jersey (526)
New York (341)
NextGen Class of 2024 (2584)
Non-profit (2117)
North Carolina (590)
Northern California (301)
Obesity (47)
Ohio (29)
Opinion (119)
Pennsylvania (209)
People (24533)
Phase I (8982)
Phase II (14886)
Phase III (13069)
Pipeline (61)
Postmarket research (1565)
Preclinical (3379)
Press Release (59)
Rare diseases (49)
Real estate (2302)
Recruiting (25)
Regulatory (9553)
Research institute (1320)
Resumes & cover letters (90)
South America (560)
Southern California (266)
Startups (1487)
Texas (86)
United States (3782)
Vaccines (332)
Washington State (131)
Weight loss (35)
Date
Today (67)
Last 7 days (415)
Last 30 days (1073)
Last 365 days (15861)
2024 (10972)
2023 (17152)
2022 (23079)
2021 (25575)
2020 (25109)
2019 (20214)
2018 (15336)
2017 (14249)
2016 (13730)
2015 (16415)
2014 (11718)
2013 (9525)
2012 (10501)
2011 (11065)
2010 (10286)
283,778 Results for "pharming group n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharming Group to participate in June 2024 investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.
June 3, 2024
·
1 min read
Pharming Group to participate in May 2024 investor conference
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of May.
May 20, 2024
·
1 min read
Pharming Group to participate in April 2024 investor conferences
Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of April:.
April 3, 2024
·
1 min read
Business
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. announces that at its Annual General Meeting of Shareholders held , all proposals were approved.
May 21, 2024
·
1 min read
Business
Pharming Group reports first quarter 2024 financial results and provides business update
Pharming Group N.V. presents its preliminary financial report for the three months ended March 31, 2024.
May 8, 2024
·
24 min read
Pharming Group to participate in February 2024 investor conferences
Leiden, The Netherlands, February 8, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of February.
February 8, 2024
·
1 min read
Business
Pharming Group reports fourth quarter and full year 2023 financial results
Pharming Group N.V. presents its preliminary financial report for the three months and full year ended December 31, 2023.
March 14, 2024
·
35 min read
Business
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
Pharming Group N.V. confirms it will report its preliminary fourth quarter and full year 2023 financial results, for the period ended December 31, on Thursday, March 14, 2024.
February 29, 2024
·
1 min read
Press Releases
Pharming Group to participate in September 2024 investor conferences
September 4, 2024
·
1 min read
Pharming Group to participate in November 2023 investor conferences
Leiden, The Netherlands, November 1, 2023: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of November:.
November 1, 2023
·
1 min read
1 of 28,378
Next
